about SonarMed®
SonarMed® was founded in 2005 to commercialize technology licensed from Purdue University to improve the placement and monitoring of endotracheal tubes (also known as endotracheal tubes, ETTs, or artificial airways) that are used in patients who cannot breathe on their own.
The technology was initially developed at Purdue University by SonarMed founders Dr. Jeffrey Mansfield, Dr. Eduardo Juan, and Dr. George Wodicka, using the principles of acoustic reflectometry to provide the medical community with a more comprehensive approach to assist in the management of endotracheal tubes.
The company’s first product – the SonarMed® AirWave™– is a non invasive, adjunctive device that provides direct, precise, real time monitoring of endotracheal tube position and function, which may aid in detecting potentially dangerous or fatal endotracheal tube conditions. The AirWave™ may help reduce endotracheal tube related risks and complications, thereby improving patient safety and quality of care as well as reducing cost of care.
Development of the SonarMed® AirWave™ was supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health and the Indiana 21st Century Research and Technology Fund.
David Wortman, Executive Chairman
Mr. Wortman is an
experienced technology executive/entrepreneur. He was a cofounder of
Pritsker and the former CEO of Made2Manage (NASDAQ: MTMS) and Mezzia. He
is currently a Venture Partner with Spring Mill Venture Partners and is
a Managing Director of Midwest Venture Partners.
Andrew Cothrel, President & CEO
Mr.
Cothrel is a seasoned medtech executive with over 20 years of
experience in general management, development/commercialization,
operations, and strategy including a Vice President/Site Manger role at
Roche and CEO roles at multiple early stage medical device and
diagnostics companies.
Jeff Mansfield, PhD, Founder and CTO
Dr.
Mansfield possesses deep expertise in biomedical acoustics. He has over
15 years of experience in medical device R&D, and was formerly a
Senior Research Scientist and Systems Engineer at Cardiac Science. He
received his B.S. in electrical engineering at Drexel University and his
M.S. and Ph.D. in electrical and computer engineering at Purdue
University.
Jim Schulz, CFO
Mr.
Schulz has over 18 years of financial experience working with Ernst
& Young, Eli Lilly, Suros and numerous startup medical technology
and life science companies. He was with Suros as they were acquired by
Hologic. He is currently a Partner at Upward Focus LLC.
Laura Lyons, VP Clinical/Quality/Regulatory Affairs
Ms.
Lyons has a strong background in all aspects of regulatory, quality,
and FDA relations with companies such as AVL and Roche. She has
consulted widely in the regulatory affairs area for top medical device
and diagnostic companies. She also has prior experience as a respiratory
therapist.
Sven Schreiber, Director of Operations
Mr.
Schreiber’s experience includes management roles in manufacturing and
quality assurance as well as roles in systems and manufacturing process
engineering at 3M and Aventis Pharmaceuticals. He is a certified Six
Sigma Greenbelt with experience in Lean Manufacturing techniques.
news
For the recent news, please visit our
news page.
events
For upcoming events, please visit our
events page.